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Single-Shot, Three-Dimensional “Non-echo” Localization
Method for In Vivo NMR Spectroscopy
In-Young Choi, Ivan Tka´cˇ, and Rolf Gruetter*
Metabolite signals with short T1 or T2 are difficult to localize
with full sensitivity. This limitation was overcome with the de-
velopment and implementation of a single-shot, complete
three-dimensional “non-echo” localization method with re-
duced sensitivity to spatial B1 variation, which is suitable for
measuring signals with very short T1 or T2, e.g., the
13C NMR
signals of glycogen. The proposed method is based on a T1-
optimized outer volume suppression scheme using pulses of
the hyperbolic secant type applied at different power levels,
which is robust over a fivefold range of T1. Strong lipid, muscle
glycogen, and glucose signals originating outside the rat brain
were suppressed. Signals of glycogen, aspartate, glutathione,
GABA C4, N-acetyl aspartate as well as the C3 and C4 signals of
glutamate and glutamine with resolved homonuclear 13C-13C
coupling were fully resolved in vivo at 9.4 Tesla using higher-
order shimming. The method can be extended to other nuclei
and to localized MRS of humans. Magn Reson Med 44:
387–394, 2000. © 2000 Wiley-Liss, Inc.
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In vivo NMR spectroscopy (MRS) allows reliable non-
invasive studies of metabolism and is a notable modality
in biochemistry and physiology (1). Using in vivo MRS,
metabolites that play significant roles in intermediary me-
tabolism can be monitored and quantified to determine the
rates of metabolic reactions taking place in vivo, thereby
leading to a better understanding of metabolism (2). How-
ever, the precise localization of fast relaxing signals in
vivo, such as those from glycogen (3), an important energy
reserve, has been challenging.
Spatial localization is desirable to eliminate signal con-
tamination from outside of the volume of interest (VOI)
and is essential for the reliable quantification of metabolite
concentrations in vivo. However, the demands placed on a
localization method are especially challenging for 13C
NMR due to the large chemical shift displacement error
and the low sensitivity. In addition, a surface coil used
often as a transceiver to increase the sensitivity results in
potential signal loss due to the spatially inhomogeneous
RF field, B1. Signal reductions due to the B1 inhomogene-
ity can be minimized for 13C NMR using three-dimen-
sional localization based on ISIS using adiabatic RF pulses
(4). Moreover, 1H-localized 13C NMR using polarization
transfer provides additional signal to noise ratio (SNR)
improvements with more precise voxel definition (5). To
minimize the signals from non-cerebral tissue in brain
studies and to reduce a large chemical shift displacement
error, more efforts on three-dimensional localization have
been added (6). Alternatively, chemical shift imaging (CSI)
can be used for localization of signals with short T2 (7).
However, limited sampling in k-space can be used only
due to the low sensitivity of 13C NMR, which results in
truncation artifacts and contamination of spectra by the
intense superficial lipid signals (8). All of the above de-
scribed localization methods suffer from signal loss when
used for the localization of weak signals with very short T1
and/or T2, such as cerebral glycogen (;5 mmol/g, T1 5
;0.3 sec, T2 5 ;6 msec). In order to detect such small
signals with very short T1 or T2 relaxation, signal attenu-
ation during RF irradiation and/or echo time delays must
be minimized. Thus, all localization methods used to date
for the 13C NMR detection of glycogen have been restricted
to one or two dimensions using a B0 spoiler (9) or 1D-ISIS
(10).
The three most frequently used localization methods are
STEAM (stimulated echo acquisition mode) (11), PRESS
(point resolved spectroscopy) (12) or ISIS (image-selected
in vivo spectroscopy) (13). When using STEAM, metabo-
lites with short transverse relaxation time (T2) can be de-
tected, since very short echo times on the order of 1 msec
can be achieved (14). However, STEAM can detect at most
half of the potential signal from the voxel, and signal
intensity can be further reduced due to T2 decay when T2
is comparable to the echo time, TE. Furthermore, incorpo-
ration of B1-insensitive RF pulses has not been achieved to
date. PRESS, on the other hand, uses the full z-magnetiza-
tion (M0), resulting in an up to twofold signal intensity
gain compared to STEAM and can be combined with adi-
abatic 180° pulses that minimize the effects of the B1
inhomogeneity (15). However, PRESS requires longer TE,
thereby limiting its use for the detection of compounds
with very short T2. Unlike STEAM and PRESS, ISIS does
not require the generation of an echo. In addition, adia-
batic pulses are easily incorporated into ISIS (4,16,17).
However, ISIS relies on inverting the magnetization in the
region of interest, which can result in signal loss due to T1
relaxation and imperfect slice profile for metabolites with
short relaxation times (16). Moreover, ISIS requires a sig-
nal addition/subtraction scheme over multiple data acqui-
sitions to select a VOI, which may increase the possibility
of incomplete signal subtraction due to subject motion in
vivo. Motion might be problematic for in vivo studies of
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intact organs, which cannot be immobilized, such as the
liver. Therefore, a single-shot, reasonably B1-insensitive
localization method that does not depend on echo-gener-
ation is needed to measure signals with very short T1 or T2
in vivo.
Localization based on outer volume suppression (OVS)
combines slice-selective saturation pulses to minimize z-
magnetization outside the VOI and has been used mainly
in conjunction with volume coils with other pulse se-
quences to enhance localization performance (18,19).
However, full three-dimensional localization based on
OVS alone has not been reported to date.
The purpose of this study was the development and
implementation of a single-shot, inversion recovery based,
non-echo (SIRENE) three-dimensional localization
method based on OVS with minimal reduction of sensitiv-
ity in the VOI for fast relaxing signals. In designing the
pulse sequence, the localization of signals with a wide
range of T1 or T2 was considered as well as the minimiza-
tion of chemical shift displacement error using broadband
hyperbolic secant (HS) pulses combined with strong gra-
dients. The performance of the sequence was tested and
verified using multi-chamber phantoms. In vivo verifica-
tion of the localization efficiency was done in the rat brain
using two distinct characteristics: (a) natural abundance
cerebral lipids in the normal brain are not detectable
(4,5,20,21) and (b) post-mortem breakdown of cerebral gly-
cogen and glucose is rapid (22). A preliminary report of
this work has appeared (23).
MATERIALS AND METHODS
NMR Methods
All experiments were performed on a 9.4 T, 31 cm bore
horizontal magnet (Magnex Scientific, UK), interfaced to a
INOVA console (Varian, Palo Alto, CA) using an actively
shielded gradient coil (Magnex Scientific, UK) with an 11
cm inner diameter, which was capable of switching to 300
mT/m in 500 msec. A quadrature 1H surface RF coil (14
mm diameter) combined with a linear three-turn 13C coil
(12 mm diameter) was built according to Adriany and
Gruetter (24). A small sphere (3 mm diameter) containing
99% 13C-enriched formic acid was placed at the center of
the 13C linear coil as an external reference. Automated
localized shimming using a fully adiabatic version of
FASTMAP (25,26) was used to adjust the currents in all
first- and second-order shim coils. The field homogeneity
resulted in a 18–26 Hz full width at half maximum of the
in vivo water signal in a nominal 500 ml volume.
Pulse Sequence
To illustrate the selected features of slice gradient orien-
tations, the following convention is used throughout this
paper: z is parallel to B0, y is parallel to the
13C coil axis
(“vertical” axis) and x denotes the orientation perpendic-
ular to the 13C coil axis and perpendicular to B0 (“horizon-
tal” axis). The pulse sequence (Fig. 1) consisted of three
stages. First, slice-selective adiabatic pulses were applied
in conjunction with gradients along x to invert the z-
magnetization in two x-slices adjacent to the VOI. Since
the sensitive volume of the RF coil extends longer along x
than along z, B1 variations and signals were estimated to be
strongest in x-slices (e.g. temporal muscle in the rat head).
To minimize the z-magnetization in these slices in a B1-
insensitive manner, the magnetization was inverted using
adiabatic RF pulses and an inversion recovery delay time
(TI) was inserted according to the measured T1 of the
signals of interest.
Second, at the time when the inverted z-magnetization
in x-slices was approaching zero, six HS pulses with nom-
inal 90° flip angles and concomitant gradients were ap-
plied to minimize the residual z-magnetization in six
slices surrounding the VOI in the following order: z, y, and
then x. Additionally, an optional alternating 180° pulse
with corresponding phase cycling was applied with a con-
comitant y gradient to select a y-slice containing the voxel
to decrease the sensitivity of the localization performance
to power settings of the OVS.
All RF pulses used for OVS were of the HS type as
described previously (27). The advantages of HS pulses are
a B1-insensitive profile even for a nominal 90° flip angle
and broad bandwidths, which minimize chemical shift
displacement error. The HS pulse shapes were tailored to
meet the specific needs of the in vivo geometry (see below)
and the RF power was adjusted to minimize the z-magne-
tization outside the VOI. Specifically, an adiabatic full-
passage (AFP), HS8 pulse (27) with 10 kHz bandwidth and
8 msec pulse duration was used for inversion in x-slices.
These pulses achieved inversion at a low peak gB1/2p of
800 Hz. Crusher gradients were applied subsequently to
dephase any residual transverse magnetization. Care was
taken in the selection of crusher gradients to avoid gener-
ation of unwanted coherences. To improve the localization
FIG. 1. Pulse sequence diagram for three-dimensional localization
based on OVS. Adiabatic pulses (HS8 modulation) were applied to
invert the z-magnetization in two x-slices adjacent to VOI. Magne-
tization in these slices followed an inversion recovery trajectory
independent of B1 and was minimized by adjusting the delay time,
TI. Residual magnetization outside of the VOI was further sup-
pressed by using six OVS pulses applied with a nominal 90° flip
angle. Slice-selection gradients are shown shaded. The thickness of
the upper and lower saturated y-slices was different to adapt to the
geometry of the rat head. Transverse magnetization was dephased
by spoiling gradients (solid black). An adiabatic half passage (AHP)
pulse was used for excitation. Bi-level WALTZ-16 was applied on 1H
channel for NOE and decoupling.
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performance along y, 6 ms long HS pulses were used with
a very narrow transition bandwidth (4.6% of the 10kHz
bandwidth at a gB1/2p of 800 Hz). 2 msec long HS pulses
with a different R-value were used along x and z to mini-
mize pulse duration and to maximize pulse bandwidth
(10kHz bandwidth at a gB1/2p of 1300 Hz). The total time
required for the OVS part of the sequence was ;160 msec
with a TI of 140 msec and 2 msec crusher gradient dura-
tion. With the presently used parameters for gradient
switching and RF pulses, the minimum possible TI was
;22 msec.
Third, an adiabatic half-passage (AHP) 90° pulse was
used for excitation immediately followed by acquisition of
the FID. Bi-level WALTZ-16 RF-pulses were applied to the
proton channel for generation of a nuclear Overhauser
effect (NOE) between excitations and for decoupling dur-
ing an acquisition time of 90 msec (28).
T1 Measurements
To optimize the inversion delay (TI in Fig. 1), T1 values of
several compounds were measured using the inversion
recovery method. The power of the adiabatic inversion
pulse was set to invert the z-magnetization in the entire
sensitive volume of the 13C coil and the repetition time
(TR) was at least five times longer than the estimated T1. T1
was determined from a three-parameter exponential curve
fit and the time required to minimize the z-magnetization
“inversion null” was calculated and experimentally con-
firmed.
Phantom Study
To test the localization efficiency, three different two-
compartment phantoms were prepared by placing a
smaller cylindrical tube (diameter of 1.4 cm) inside a
larger cylindrical tube (diameter of 2.7 cm) with length of
10 cm: (a) 250 mM glutamine (inner compartment) and
2 M acetate (outer compartment); (b) 100 mM myo-inositol
(inner compartment) and 300 mM oyster glycogen (outer
compartment) solution; and (c) 100 mM glucose (inner
compartment) and 400 mM oyster glycogen (outer com-
partment) solution. Two different compounds (e.g., acetate
and glycogen) were placed into the outer compartments of
these three phantoms in order to test the localization per-
formance of the sequence on signals with a wide range of
relaxation times. To imitate various in vivo geometries,
(e.g., the muscles on top of the brain being thinner than the
temporal muscles) two different phantom geometries were
used: To test the sensitivity of the OVS performance on the
thickness of the y-slice, the position of the inner cylinder
relative to the outer cylinder was varied from 1.8 mm to
3.4 mm.
Animal Preparation
The study was approved by the Institutional Animal Care
and Use Committee (IACUC) and followed the guidelines
for the care and use of laboratory animals at the University
of Minnesota. a-chloralose anesthetized male Sprague-
Dawley rats (245 6 12 g, n 5 5) were intubated and
ventilated with a pressure-driven ventilator (Kent, Litch-
field, CT) with a 60:40 mixture of O2 and N2O gases.
Catheters were inserted in the femoral artery and veins for
blood gas analysis, a-chloralose and glucose infusion, and
physiological monitoring of blood pressure and heart rate.
The animals were then placed in an acrylic holder at-
tached to an insert in the gradient coil. The body temper-
ature of animals was maintained at 37°C with a warm
water circulation system using the feedback of a rectal
temperature probe (Cole Palmer, Vernon Hills, IL). Physi-
ological parameters were adjusted and maintained within
the normal range throughout the experiments. [1-13C] D-
glucose (99% enriched, 20% weight/volume solution, Iso-
tec Inc., Miamisburg, OH) was infused into the femoral
vein according to a previously described protocol (22).
RESULTS
Phantom Experiments
Three two-compartment phantoms were used to test the
localization performance of the developed pulse sequence
(Fig. 1). A criterion for the quality of the localization was
complete elimination of signals originating from the outer
chambers. The delay time (TI) was based on T1 measure-
ments. The VOI (;500 ml nominal volume) was placed in
the inner cylinder (Fig. 2a). The adiabatic HS8 pulses
inverted the z-magnetization in x-slices with minimized
B1 sensitivity. After the delay TI, the z-magnetization in
the x-slices approached zero. Because of the adiabatic
inversion pulses, the reduction of the longitudinal magne-
tization was independent of B1 but dependent on TI rela-
tive to T1. Magnetization was further reduced by using
additional RF pulses with a nominal 90° flip angle whose
FIG. 2. Validation of three-dimensional localization efficiency on
signals with long T1. a:
1H image of a coaxial two-compartment
phantom containing 2 M natural abundance acetate (outer compart-
ment) and 250 mM L-glutamine (inner compartment) acquired in the
xy-plane using a FLASH sequence (TR 5 10 msec, TE 5 5 msec).
The selected VOI is shown as a rectangle in the image. b: The sixfold
stronger acetate signal from outside the VOI (top trace) was com-
pletely suppressed into the noise level when localization was ap-
plied (bottom trace) (TR 5 3 sec, nt 5 256, TI 5 1.4 sec).
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power was then optimized to suppress the outer volume
signals in z, y, and x-slices completely. The RF power was
adjusted for each experiment based on 180° flip angle
measurements on an external reference signal (13C formic
acid). RF power of all OVS pulses was calibrated based on
the ratio between the power requirements for the 180°
pulse on the formic acid signal relative to the OVS pulses,
which was experimentally determined in phantoms. Lo-
calization performance was insensitive to the power set-
ting of the nominal 90° OVS pulses within 6 2 dB.
Figure 2a shows a transverse 1H image of a coaxial
two-chamber phantom containing glutamine inside and
acetate outside. To demonstrate the performance of the
localization, 13C NMR spectra were acquired from this
phantom with and without localization (Fig. 2b). The top
trace shows the unlocalized spectrum, which includes the
signals of glutamine and acetate from both inner and outer
compartments. The bottom trace shows the localized spec-
trum, in which the more than sixfold higher signal of
acetate with very long T1 (T1 5 ;7 sec) from the outer
compartment was completely eliminated with minimal
reduction of the glutamine signal from inner compartment
(TI 5 1.4 sec).
A transverse image of a two-compartment phantom
mimicking more closely the in vivo geometry (e.g., rat
head) was obtained using a FLASH sequence (Fig. 3a). In
the unlocalized spectrum, signals from both myo-inositol
and glycogen were clearly observed (Fig. 3b, bottom trace),
whereas in the localized spectrum (Fig. 3b, top trace) the
glycogen signals from the outer cylinder were within the
noise, thereby illustrating the localization efficiency of the
method for oyster glycogen (T1 5 0.34 6 0.01 sec, mean 6
standard deviation, n 5 7). In conjunction with Fig. 2, this
demonstrates the performance of the pulse sequence in a
wide range of T1 from ;0.3 to ;7 sec, which is a 20-fold
variation, while the TI was varied from 0.14 to 1.4 sec.
13C images were used to demonstrate the localization
efficiency of the sequence shown in Fig. 1 (Fig. 4). The 13C
images of a phantom containing a 20% weight/volume
solution of 99% enriched [1-13C] glucose were acquired
with a gradient-echo readout (TR 5 965 msec, TE 5 2.1
msec, 64 phase encoding steps, number of transients 5
128, FOV 5 3 3 3 cm2, slice thickness 5 3 mm) following
the OVS pulses. Without OVS, this image (Fig. 4a) showed
the sensitive volume of the 13C coil. The nominal VOI
(8.5 3 6 3 10 mm3) is indicated by the dotted rectangle in
Fig. 4a. Fig. 4b shows that signals from outside the VOI
were well suppressed by applying the OVS pulses prior to
the image acquisition, indicating a good voxel definition of
the localization method. The reference frequency for the
VOI selection was set to the C1 resonance of b-glucose at
96.8 ppm. The sphere containing the 99% formic acid was
thus displaced by ;3 mm due to the chemical shift differ-
ence relative to the glucose C1 resonance, consistent with
the readout gradient of 200 mT/m corresponding to 21.3
kHz/cm and the chemical shift difference of ;70 ppm 5 7
kHz.
In Vivo Experiments
A 500 ml VOI was placed in the rat brain on the midline
and 1.5 mm posterior to the bregma. The power of the RF
pulses was calculated from the pulsewidth needed to in-
vert magnetization of the 13C formic acid signal from the
sphere located at the center of the linear 13C coil. Follow-
ing this measurement, which assesses variability in coil
loading, no further RF power adjustment of the six 90°
OVS pulses was made. Thus no time was required to
optimize OVS. To optimize TI for glycogen, lipids and
other amino acids, T1 measurements were performed us-
FIG. 3. Localization efficiency for a signal with short T1
(glycogen). a: 1H image of the two-compartment
phantom, 400 mM oyster glycogen (outer compart-
ment, T1 5 ;0.3 sec) and 100 mM myo-inositol (inner
compartment), mimicking in vivo geometry of the rat
brain acquired using a FLASH sequence. b: To dem-
onstrate of the localization efficiency for glycogen sig-
nals, 13C spectra were acquired with localization (top
trace) and without localization (bottom trace). The gly-
cogen signals in the localized spectrum were sup-
pressed well into the noise level (TR 5 1 sec, nt 5
1000, TI 5 0.14 sec). The localization reference fre-
quency was set to 100.6 ppm.
FIG. 4. 13C MRI of the three-dimensional localization efficiency of
the sequence in Fig. 1. a: 13C image of [1-13C] glucose phantom was
acquired using a gradient-echo readout following OVS localization
(TE 5 2.1 msec, TR 5 965 msec, 64 phase encoding steps). The
dashed rectangle in the image indicates the location of the selected
voxel. The bright spot was from the sphere containing 99% en-
riched 13C formic acid at the center of 13C coil, consistent with the
chemical shift displacement in the readout direction (x-axis). The
13C-image acquisition following OVS (b) shows excellent correspon-
dence to the selected voxel shown in the unlocalized image (a). The
dark band within the selected volume corresponds to the area of
inverted z-magnetization due to the use of surface coil and Gauss-
ian RF pulses used for excitation.
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ing the inversion recovery method. The T1 of glycogen C1
in vivo was 0.33 6 0.03 sec and that of lipids was 0.59 6
0.04 sec. The T1 of several metabolites in vivo including
glutamate C4, GABA C2, and lipid are shown in Table 1.
Examples of the measured inversion recovery time courses
are shown in Fig. 5.
Figure 6 shows an in vivo localized 13C NMR spectrum
acquired with the sequence and a corresponding trans-
verse 1H image of the rat brain. The localization method
completely eliminated the extraneous methylene lipid sig-
nals that resonate at ;30.5 ppm (T1 5 ;0.6 sec, Table 1)
confirming the effectiveness of the localization. A well-
defined volume within the brain and localized higher-
order shimming resulted in an excellent spectral resolu-
tion demonstrated by the resolved homonuclear 13C-13C
coupled spin systems (JCC 5 34 Hz) of the glutamate C4
and C3 resonances. In addition, homonuclear coupling
was detected in the glutamine C4 and C3, the aspartate C3
and the GABA C3 resonances. All glutamine resonances
and the glutathione resonance at 32.16 ppm were com-
pletely resolved from glutamate at 9.4 Tesla. Additionally,
the GABA C4 resonance at 40.35 ppm was discernible
from the resonance of NAA C3. Such a level of in vivo
specificity has not been reported to date. The sequence
also provided excellent sensitivity, as illustrated by the
detection of the NAA and lactate methyl resonances using
NOE enhancement.
To further confirm the localization performance, we ob-
served the rapid post-mortem degradation of brain glyco-
gen compared to muscle glycogen. The localized glycogen
and glucose signals reduced to the noise level within a few
minutes while the unlocalized signal persisted for several
hours, as described elsewhere (22). Specifically, the simul-
taneous detection of muscle glycogen and glucose signals
in spectra from the post-mortem rat head and their elimi-
nation upon localization (Fig. 2 in Ref. 22) further illus-
trated the ability of the sequence to simultaneously pro-
vide accurate localization of signals with widely different
T1 as illustrated for glucose and glycogen in Table 1.
DISCUSSION
In this paper, we report the development and implemen-
tation of a single-shot three-dimensional localization
method for in vivo 13C NMR spectroscopy based on outer
volume suppression (OVS). To minimize sensitivity to B1
variations, typically encountered when using surface
coils, the OVS method used inversion recovery in x-slices,
having the largest B1 inhomogeneity and most stringent
requirements for suppressing signal from outside the VOI.
Excellent performance of the localization of signals with a
relatively short T1, such as glycogen (T1 5 ;0.3 sec, Table
1) and extraneous lipid resonances (T1 5 ;0.6 sec, Table
1), became possible for the first time as shown in (22) and
in Fig. 6. The T1 of glycogen measured in the rat brain
(Table 1) was comparable to the T1 of oyster glycogen
(0.34 6 0.01 sec) at 9.4 T and similar to the T1 of oyster and
liver glycogen at 8.4 T (29). These results are in agreement
with a recent study that showed the T1 of glycogen was
independent of molecule size, temperature, and possibly
structure (30).
Although localization of signals with a short T1 was
emphasized in the current implementation, we demon-
strated accurate localization of signals with longer T1.
Since in vivo T1 values varied between 0.3 sec (glycogen
C1) and 1.5 sec (glucose C1), adjustments of the delay TI in
the pulse sequence (Fig. 1) was minimal. Evidence that
accurate localization is simultaneously possible for signals
covering the range of typical in vivo T1 (Table 1) was
provided by the simultaneous elimination of both muscle
FIG. 5. Inversion recovery trajectories of in vivo signals at 9.4 Tesla.
The T1 of glycogen C1 and other metabolites were measured in vivo
from a rat head using the inversion recovery method (delay between
excitations 5 7.5 sec; number of transients was 40 for glycogen and
glucose, and 80 for lipid, GABA, and glutamate). The lines are the
best three-parameter fit to the corresponding data. The open-trian-
gles, the filled-triangles, filled circles, open squares, and open dia-
monds indicate the normalized intensity of in vivo cerebral glycogen
C1 (100.64 ppm), lipid (30.50 ppm), GABA C2 (35.12 ppm), gluta-
mate C4 (34.27 ppm), and glucose C1 (96.80 ppm) signals, respec-
tively. More T1 values averaged from several studies are listed in
Table 1. For these T1 measurements and those in Table 1, the
nominal volume was increased threefold.
Table 1
In Vivo T1 of
13C NMR Resonances
Metabolites 13C chemical shift (ppm) T1 (sec)
Glycogen C1 100.64 0.33 6 0.03b
Glucose C1b 96.80 1.48 6 0.13b
Lipid 30.50 0.59 6 0.04b
Glutamate C4 34.27a 1.27 6 0.05
Glutamine C4 31.66 1.22 6 0.06
Glutamate C3 27.74 1.17 6 0.12
Glutamine C3 27.08 1.23 6 0.23
Aspartate C3 37.36 1.33 6 0.11
N-acetyl-aspartate C3 40.45 1.07 6 0.18
GABA C2 35.12 1.28 6 0.35
*T1 of extracerebral lipid and of metabolite signals from the rat brain
in vivo at 9.4 T. T1 values were obtained by a non-linear three-
parameter exponential curve fit.
a13C chemical shifts were referenced relative to the Glutamate C4
peak based on Barany et al. (39) except for the glycogen C1 peak,
which was referenced to the b-glucose C1 peak (96.8 ppm).
bT1 values were estimated from five measurements (mean 6 stan-
dard deviation) and all other T1 values were from four measurements
in three animals.
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glucose and glycogen signals in the post-mortem rat brain
for a given TI (22). Thus, the proposed method enabled
simultaneous detection of in vivo signals with both short
T1 and long T1 as well as short and long T2. Most reso-
nances from small molecules in vivo (e.g., neurotransmit-
ters and amino acids) appear to have similar T1 values to
that of glucose (Table 1 and Fig. 5), which provides evi-
dence for reliable and well-defined localization for most
signals detected in Fig. 6.
Minimizing the chemical shift displacement error is of
critical importance for direct-detected in vivo 13C NMR
spectroscopy. In our implementation at 9.4 T, the chemical
shift difference of 70 ppm (between the glucose C1 and
glutamate C3 resonances) was at most 2.7 mm when using
245 mT/m gradients. We used broadband hyperbolic se-
cant pulses of the HS8 type (27), which provided a 10 kHz
bandwidth and achieved full inversion at an RF power
corresponding to gB1/2p 5 800 Hz. Likewise, the 6 msec
and 2 msec long HS pulses produced a nominal 90° flip
angle at a gB1/2p of 800 Hz and 1300 Hz, respectively.
Therefore, we conclude that the demands on peak RF
power must be considered very modest for a small surface
coil such as the one used in this study (12 mm diameter).
When larger RF coils and weaker gradients are used, the
chemical displacement error is expected to be more prom-
inent. However, the method will still provide accurate
three-dimensional localization for glycogen and glucose
C1 resonances. For example, considering at 1.5 T the
chemical shift difference between glucose C1 and glycogen
C1 (;7 ppm, i.e. ;110 Hz), HS pulses with 5 kHz band-
width (a peak gB1/2p of 400 Hz) and 10 mT/m gradients
(corresponding to ;1 kHz/cm at the 13C frequency) result
in a chemical displacement error of only 2.2% of the voxel
dimension, which increases to 22% for a 70 ppm chemical
shift range. Such small displacement errors are well
within the tolerance for in vivo human applications and
point to the potential simultaneous localized detection of
the glutamate C4 and glucose C1 resonance at 1.5 Tesla. In
this example, it should be stressed that the limiting factor
is the assumed available gradient strength. A 3 Tesla sys-
tem, for example, with 20 mT/m gradient strength and a
peak gB1/2p of 1 kHz (10 kHz bandwidth) results in iden-
tical chemical shift displacement errors.
Since the localization part of the sequence does not
affect magnetization inside the VOI, the proposed local-
ization method can be combined with low flip angle exci-
FIG. 6. 3D-localized in vivo 13C NMR spectrum of the rat brain using the single-shot method shown in Fig. 1. The spectrum was acquired
in 38 min from the rat brain (TR 5 1.5 sec, TI 5 0.2 sec) 3.5 hr after starting a 99%-enriched [1-13C] D-glucose infusion from a nominal 500
ml volume. Resonances were identified based on previously reported chemical shifts (40). Homonuclear 13C -13C coupling was observed
due to label scrambling in the TCA cycle (20) in glutamate C3 and C4, glutamine C3 and C4, aspartate C3, and GABA C3. In addition, the
signal of GABA C4 was resolved from that of NAA C3 and glutathione (GSH) labeling was detected. The spectrum is shown with 3 Hz
Gaussian resolution enhancement applied prior to zero-filling and fast Fourier transformation (FFT). No baseline correction was applied. The
inset shows the transverse 1H image placed 1 mm superior (along y) to the center of the VOI. The rectangle indicates the dimension of the
nominal VOI (8.5 3 6 3 10 mm3).
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tation and short TR, provided the TI is adjusted accord-
ingly, which increases SNR per unit time. The observed
insensitivity to spatial B1 variations and low peak RF
power requirements of the OVS pulses implies that the
method can also be applied when volume coils are used
for RF transmission with minimal RF power adjustments.
However, the specific absorption rate (SAR) will be in-
creased and the SNR decreased when detecting with a
volume coil. In addition, larger outer volume signals need
to be suppressed.
For nuclei where the signals that need to be suppressed
are not too large and T1 or T2 are similar to the range
encountered in this study, we expect that the proposed
scheme will be equally applicable, such as localized MRS
of 15N and 31P and possibly 23Na as well as CSI of 1H (31),
or when using 1H localization combined with polarization
transfer to 13C (5,20,32).
To our knowledge, this is the first study to report the
acquisition of fully 3D-localized, direct detected 13C NMR
signals of the rat brain in vivo. Most studies of the rat brain
have been hampered by a requirement to subtract a base-
line spectrum containing the natural abundance lipid sig-
nals (33). Thus spectra are more prone to small variations
in system stability and motions of the animal. Further-
more, elimination of the acquisition of such a natural
abundance reference spectrum naturally increases the
SNR and decreases experimental time, leading to a com-
pounded increase in sensitivity. It should be emphasized
that although a nominal volume size was specified based
on the slice-selection parameters, the effective volume is
much smaller due to the spatial characteristic of the RF
field of the surface coil. For example, when assuming that
the sensitive volume of the RF coil equals a half-sphere of
equal diameter, a sensitive volume of a 12 mm diameter
13C coil is approximately 400 ml. Therefore, the VOI re-
ported in this paper represents the dimensions selected by
the gradient-based localization and can be considered as
nominal. Thus the effective volume size is much smaller
and probably corresponds to 250 ml.
In conjunction with higher-order shimming based on
FASTMAP, we consistently achieved narrow linewidths
on the order of 20 Hz for in vivo water, which allowed the
routine detection of 13C-13C isotopomers in glutamate and
glutamine C3 and C4 as well as in aspartate C3. This is to
our knowledge the first in vivo detection of isotopomer
signals in glutamate, glutamine, and aspartate in the ani-
mal brain upon infusion of singly labeled glucose. Obser-
vation of these multiplets, which reflects label scrambling
due to TCA cycle activity (2,34), extends previous in vitro
isotopomer analysis (35) to the in vivo case. The demon-
strated resolution and information content of spectra such
as the one shown in Fig. 6 imply the feasibility of meta-
bolic modeling of data obtained from the rodent brain
using models of similar and higher complexity as recently
proposed for human brain at 4 Tesla (20). In addition, we
were able to directly detect the C4 resonance of GABA
resolved from the adjacent NAA C3 resonance, the multi-
plet of GABA C3, and the 13C glutamate C4 resonance of
glutathione (GSH Glu C4) for the first time in vivo. The
GSH Glu C4 resonance, present in the brain at a sufficient
concentration to be detected in vivo by 1H NMR (36,37),
was consistently observed at 32.16 ppm. We also noted a
small, but consistent labeling of the lactate C3 resonance
(Fig. 6). Although direct 13C NMR detection may suffer
from reduced sensitivity, the method provides much
higher chemical specificity and spectral resolution com-
pared to the indirect 1H NMR detection (38).
To date, no localized three-dimensional spectroscopy of
glycogen has been reported in humans. Provided that the
FDA guidelines for SAR are enforced, the proposed
method should be easily transferable to the studies of
human glycogen metabolism. In this context, it should be
stressed that peak RF power cannot be considered to be a
limiting factor for human applications, since the employed
pulses can be tailored to perform at very low peak B1. The
resulting improved three-dimensional definition of the
VOI is expected to improve reliability and reproducibility
of studies of glycogen metabolism in the human liver,
muscle, and heart.
CONCLUSIONS
In this study, a single-shot, inversion recovery based, non-
echo (SIRENE) three-dimensional localization method for
in vivo spectroscopy was developed. We demonstrated for
the first time single-shot, three-dimensional localized 13C
NMR spectroscopy in the rat brain in vivo with minimal
sensitivity reduction. Improved sensitivity was illustrated
by the detection of the C4 resonance of GABA resolved
from the C3 of NAA, the detection of the multiplet of
GABA C3, and glutathione (GSH) labeling for the first time
reported in 13C NMR in vivo. Fully resolved signals of
intermediary metabolites including lactate, GABA C2, glu-
tamate and glutamine C3,4 isotopomers, and aspartate C3
isotopomers were detected. We conclude that the pro-
posed localization method should be applicable for other
nuclei such as 15N, 23Na and 31P. Moreover, it can be
adapted to human applications for the detection of signals
from metabolites of low concentrations with various
ranges of T1 and T2 values. The combination of complete
three-dimensional localization and excellent sensitivity
will help further understanding of brain glycogen metab-
olism in the human brain in vivo.
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